VEGFR1-770/VEGFR1-1084 peptide vaccines (Kinki University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVEGFR1-770/VEGFR1-1084 peptide vaccines (Kinki University)

Drug Alias NameR1-770 + R1-1084VEGFR1-770/VEGFR1-1084 peptide vaccinesVEGFR1-770 (TLFWLLLTL)/VEGFR1-1084 (SYGVLLWEI) peptide vaccinesVEGFR1-770 (HLA-A0204 restricted)/VEGFR1-1084 (HLA-A2402 restricted) peptide vaccines

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionVascular endothelial growth factor receptor 1 modulators

TargetsVascular endothelial growth factor receptor 1

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tokyo Kindai University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Tokyo Kindai University

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A